Narazaciclib not checked

Hangzhou Hanx Biopharmaceuticals, Ltd. · HX301 · HX301 Monolactate Capsules

FollowEvery change as it happens, and a Monday email
Stage
 
Next date
Phase 1/2 trial completes
Trials
1 active
4 in total
Targets
 

What this is

How it works
Blocks CDK enzymes that let cells divide, to slow the growth of cancer cells.-ciclib: cyclin-dependent kinase inhibitors WHO name stem
How it’s given
“Part I: It is planned to firstly explore a dose of 160 mg and enroll approximately 3-6 subjects to receive HX301 monotherapy until disease progression, intolerable toxicity, or other reasons for stopping treatment for up to 24 cycles of 28 days each. Safety evaluation was performed using the traditional "3 + 3" rule, and the DLT observation period was 28 days (C1D1 \~ C1D28). If 160 mg was not…”In the company’s words, NCT06703255 on ClinicalTrials.gov
Tested for
Glioma
Main trialPhase 1/2
“The study will include a dose-escalation and dose-expansion component to establish the recommended Phase 2 dose (RP2D) for HX301 in combination with Temozolomide and to evaluate the preliminary antitumor activity of HX301.HX301 is an investigational drug that has not yet been approved by the Food and Drug Administration (FDA) or any other regulatory authorities for commercial purposes.”In the company’s words, NCT06703255 on ClinicalTrials.gov
Other names
HX301 · HX301 Monolactate Capsules · ON123300 · ON 123300 · HX-301

Other drugs for Glioma

All 125 drugs for Glioma

Coming up1

Changes0

Last 90 days

No changes yet. We started recording changes on 6 Nov 2026.

Trials4

TrialPhaseCompletesWhat it tests
Phase 1/2Recruiting 31 Dec 2026 A Phase 2 Study of HX301 in Patients with High-grade Giloma
Phase 1/2Unknown Jan 2026 Study of Narazaciclib (ON 123300) Plus Letrozole in Endometrial Cancer and Other Gynecologic Malignancies
Phase 1Completed 12 Jan 2024 The Tolerability and Pharmacokinetics of HX301 Monolactate Capsules in Patients With Advanced Solid Tumors
Phase 1Unknown Oct 2024 Study of ON 123300 in Patients With Advanced Cancer
A trial in both registries shows both numbers.

About

Sources
ClinicalTrials.gov updated 18 Nov 2026 · EU trials register (CTIS) updated 18 Nov 2026 · openFDA updated 17 Nov 2026

Follow Narazaciclib

Following is part of Solo: you see every change to Narazaciclib the day it happens.

Solo

$49a month, excl. VAT

  • Follow up to 5 landscapes, companies or drugs
  • Every change, the day it happens
  • A Monday email with the week’s changes
Choose Solo

Free

$0no card

  • One landscape of your own, in full
  • The top 10 of everything else
Sign up free

Have an account? Sign in